Literature DB >> 8430062

Prodrugs of peptides. 18. Synthesis and evaluation of various esters of desmopressin (dDAVP).

A H Kahns1, A Buur, H Bundgaard.   

Abstract

Various aliphatic carboxylic acid esters and a carbonate ester of the tyrosine phenolic group in desmopressin were synthesized to assess their suitability as prodrugs with improved bioavailability compared to the parent peptide. The chemical stability of the esters in aqueous solution was similar to that of simple phenol esters. The derivatives were quantitatively converted to desmopressin by enzymatic hydrolysis in human plasma and rabbit liver homogenate. The esters with a straight side chain were rapidly hydrolyzed by alpha-chymotrypsin, but the sterically hindered pivalate ester proved more stable than desmopressin itself toward this proteolytic enzyme. All the esters were more lipophilic than desmopressin in terms of octanol-buffer partition coefficients. The transport of the compounds across confluent monolayers of Caco-2 cells was examined. No correlation between permeability and lipophilicity was found but the pivalate ester showed a markedly higher flux relative to desmopressin. It is concluded that appropriate esterification of desmopressin at its tyrosine group may be a potentially useful prodrug approach.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8430062     DOI: 10.1023/a:1018973029651

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  19 in total

1.  Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa.

Authors:  A R Hilgers; R A Conradi; P S Burton
Journal:  Pharm Res       Date:  1990-09       Impact factor: 4.200

2.  The influence of peptide structure on transport across Caco-2 cells.

Authors:  R A Conradi; A R Hilgers; N F Ho; P S Burton
Journal:  Pharm Res       Date:  1991-12       Impact factor: 4.200

3.  Desolvation energy: a major determinant of absorption, but not clearance, of peptides in rats.

Authors:  M S Karls; B D Rush; K F Wilkinson; T J Vidmar; P S Burton; M J Ruwart
Journal:  Pharm Res       Date:  1991-12       Impact factor: 4.200

4.  Effects of proteolytic enzyme inhibitors on the nasal absorption of vasopressin and an analogue.

Authors:  K Morimoto; H Yamaguchi; Y Iwakura; M Miyazaki; E Nakatani; T Iwamoto; Y Ohashi; Y Nakai
Journal:  Pharm Res       Date:  1991-09       Impact factor: 4.200

5.  Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells.

Authors:  P Artursson; J Karlsson
Journal:  Biochem Biophys Res Commun       Date:  1991-03-29       Impact factor: 3.575

6.  Absence of HeLa cell contamination in 169 cell lines derived from human tumors.

Authors:  J Fogh; W C Wright; J D Loveless
Journal:  J Natl Cancer Inst       Date:  1977-02       Impact factor: 13.506

7.  Prodrugs of peptides. 13. Stabilization of peptide amides against alpha-chymotrypsin by the prodrug approach.

Authors:  A H Kahns; H Bundgaard
Journal:  Pharm Res       Date:  1991-12       Impact factor: 4.200

8.  Pharmacokinetics and haematological effects of desmopressin.

Authors:  M Köhler; A Harris
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

9.  Metabolism of testosterone during in vitro transport across CACO-2 cell monolayers: evidence for beta-hydroxysteroid dehydrogenase activity in differentiated CACO-2 cells.

Authors:  A Buur; N Mørk
Journal:  Pharm Res       Date:  1992-10       Impact factor: 4.200

10.  Resistance of 1-deamino-[8-D-arginine]-vasopressin to in vitro degradation as compared with arginine vasopressin.

Authors:  K Matsui; T Kimura; K Ota; K Iitake; M Shoji; M Inoue; K Yoshinaga
Journal:  Endocrinol Jpn       Date:  1985-08
View more
  3 in total

1.  N-glycosylation of Campylobacter jejuni surface proteins promotes bacterial fitness.

Authors:  Abofu Alemka; Harald Nothaft; Jing Zheng; Christine M Szymanski
Journal:  Infect Immun       Date:  2013-03-04       Impact factor: 3.441

2.  Basics and recent advances in peptide and protein drug delivery.

Authors:  Benjamin J Bruno; Geoffrey D Miller; Carol S Lim
Journal:  Ther Deliv       Date:  2013-11

3.  Development and Validation of a Reversed-Phase High-performance Liquid Chromatography Method for Determination of Desmopressin in Chitosan Nanoparticles.

Authors:  S M Taghizadeh; F Mohamadnia; L Adlnasab
Journal:  Indian J Pharm Sci       Date:  2013-03       Impact factor: 0.975

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.